In conclusion, this analysis, although preliminary, suggests the deregulation of the PIM pathway in rheumatic diseases and stimulates in-depth studies of PIM kinases’ involvement in chronic inflammatory arthropathies. This evidence concerns the gene PIM1 and rheumatic disorder.